Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

for
Cancer, Predictive Cancer Model, Effects of Chemotherapy
Location: Durham NC, Rochester MN, Houston TX
Sponsor: Known Medicine, Inc.

Sex: All

Age: 18+

Code: NCT05338073

Recruiting

Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

for
Cancer, Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06667427

Recruiting

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

for
Refractory Acute Leukemia, Pediatric Relapsed
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT06397027

Phase 1, Recruiting

A Study of BG-C477 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: New Haven CT, Hackensack NJ, Peoria IL, Jackson MS,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06596473

Phase 1, Recruiting

Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)

for
Cancer
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05413473

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

for
Malignant Solid Neoplasm,
Location: Bethesda MD, Jacksonville FL, Rochester MN,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03750227

Phase 3, Recruiting

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

for
Solid Tumor, Adult
Location: Boston MA, New Haven CT, Pittsburgh PA, Orlando FL,
Sponsor: Ribon Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04053673

Phase 1, Recruiting

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Scottsdale AZ
Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Sex: All

Age: 18+

Code: NCT03398720

Phase 1, Recruiting

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

for
Advanced Solid Tumors
Location: New York NY, Pittsburgh PA
Sponsor: AskGene Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05867420

Phase 1, Phase 2, Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

for
Lymphoma, Malignant Solid Neoplasm
Location: Lake Success NY, Chesapeake VA, Newark DE, Scranton PA,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT05006482

Phase 3, Recruiting

Evaluation of Depression and Anxiety in Chemotherapy Patients

for
Oncology Problem
Location: Staten Island NY
Sponsor: Richmond University Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03552731

Recruiting

Prospective Study of oncRNA Stratification of Cancer by Size and Stage

for
Cancer
Location: Reno NV, Palo Alto CA
Sponsor: Exai Bio Inc.

Sex: All

Age: 18+

Code: NCT05833360

Recruiting

Ovarian Tissue Freezing For Fertility Preservation

for
Malignancy, Fertility
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: Female

Age: 18 - 41

Code: NCT00902720

Recruiting

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT05705492

Phase 2, Recruiting

Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors

for
Solid Tumor
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 1 - 70

Code: NCT05238792

Phase 1, Recruiting

Breast Cancer Liquid Biopsy Trial

for
Breast Cancer, Cancer
Location: Bronx NY, New York NY, Hollywood FL, Orlando FL,
Sponsor: Anthony Magliocco

Sex: All

Age: 18+

Code: NCT04962529

Recruiting

Characterization of Hyperpolarized Pyruvate MRI Reproducibility

for
Malignant Solid Tumors
Location: New York NY, Montvale NJ
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 21 - 70+

Code: NCT02421380

Recruiting

Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.

for
Sarcoid, Cardiovascular Diseases, Cancer
Location: Boston MA
Sponsor: Ralph Weissleder, MD

Sex: All

Age: 18 - 70+

Code: NCT04843891

Phase 1, Recruiting

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

for
Diabetes, Cancer, Multiple Sclerosis, Arthritis,
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT02777060

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase 1, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial